The evolving role of radiation therapy as treatment for liver metastases

Romesser, 2021, External Beam Radiation Therapy for Liver Metastases, Surg Oncol Clin N Am, 30, 159, 10.1016/j.soc.2020.08.006 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Garden, 2006, Guidelines for resection of colorectal cancer liver metastases, Gut, 55, iii1, 10.1136/gut.2006.098053 Hellman, 1995, Oligometastases, J Clin Oncol, 13, 8, 10.1200/JCO.1995.13.1.8 Seo, 2014, Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer, World J Gastroenterol, 20, 2005, 10.3748/wjg.v20.i8.2005 Aitken, 2015, Stereotactic body radiotherapy for liver metastases, Clin Oncol (R Coll Radiol), 27, 307, 10.1016/j.clon.2015.01.032 Ruers, 2017, Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial, J Natl Cancer Inst, 109, djx015, 10.1093/jnci/djx015 Wei, 2006, Survival after hepatic resection for colorectal metastases: a 10-year experience, Ann Surg Oncol, 13, 668, 10.1245/ASO.2006.05.039 Hewish, 2011, First-line treatment of advanced colorectal cancer, Lancet, 377, 2060, 10.1016/S0140-6736(11)60788-5 Wieners, 2011, Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study, Radiother Oncol, 100, 314, 10.1016/j.radonc.2011.03.005 Petrelli, 2018, Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review, Radiother Oncol, 129, 427, 10.1016/j.radonc.2018.06.035 Dawson, 2000, Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J Clin Oncol, 18, 2210, 10.1200/JCO.2000.18.11.2210 Timmerman, 2014, Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice, J Clin Oncol, 32, 2847, 10.1200/JCO.2014.55.4675 Gupta, 2020, Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma, Rep Pract Oncol Radiother, 25, 293, 10.1016/j.rpor.2019.12.006 Tsang, 2016, Stereotactic body radiotherapy: current strategies and future development, J Thorac Dis, 8, S517, 10.21037/jtd.2016.03.14 Mazloumi, 2021, The presence of contrast agent increases organ radiation dose in contrast-enhanced CT, Eur Radiol, 31, 7540, 10.1007/s00330-021-07763-7 Ramm, 2001, Influence of CT contrast agents on dose calculations in a 3D treatment planning system, Phys Med Biol, 46, 2631, 10.1088/0031-9155/46/10/308 Kamal, 2021, Dosimetric impact of contrast-enhanced 4d computed tomography for stereotactic body radiation therapy of hepatocelluar carcinoma, Rep Pract Oncol Radiother, 26, 598 Kavanagh, 2011, Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation, Cancer J, 17, 177, 10.1097/PPO.0b013e31821f7dbd Chetvertkov, 2020, NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery, Front Oncol, 10, 10.3389/fonc.2020.602607 Henke, 2018, Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen, R Radiother Oncol, 126, 519, 10.1016/j.radonc.2017.11.032 Finkelstein, 2011, The confluence of stereotactic ablative radiotherapy and tumor immunology, Clin Dev Immunol, 2011, 10.1155/2011/439752 Marciscano, 2021, Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities, Int J Radiat Oncol Biol Phys, 110, 35, 10.1016/j.ijrobp.2019.02.046 Hoyer, 2006, Phase II study on stereotactic body radiotherapy of colorectal metastases, Acta Oncol, 45, 823, 10.1080/02841860600904854 Kavanagh, 2006, Interim analysis of a prospective phase I/II trial of SBRT for liver metastases, Acta Oncol, 45, 848, 10.1080/02841860600904870 Rusthoven, 2009, Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases, J Clin Oncol, 27, 1572, 10.1200/JCO.2008.19.6329 Lee, 2009, Phase I study of individualized stereotactic body radiotherapy of liver metastases, J Clin Oncol, 27, 1585, 10.1200/JCO.2008.20.0600 Scorsetti, 2013, Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial, Int J Radiat Oncol Biol Phys, 86, 336, 10.1016/j.ijrobp.2012.12.021 Scorsetti, 2018, Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up, Radiat Oncol, 13, 234, 10.1186/s13014-018-1185-9 Hong, 2017, Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype, J Natl Cancer Inst, 109, 10.1093/jnci/djx031 Folkert, 2021, Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases, Int J Radiat Oncol Biol Phys, 109, 1387, 10.1016/j.ijrobp.2020.12.012 Rule, 2011, Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases, Ann Surg Oncol, 18, 1081, 10.1245/s10434-010-1405-5 Cazic, 2020, Stereotactic Body Radiation Therapy (SBRT) for Liver Oligometastases: Outcomes and Safety, Acta Med Acad, 49, 225, 10.5644/ama2006-124.311 Nicosia, 2020, Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases, J Cancer Res Clin Oncol, 146, 2351, 10.1007/s00432-020-03223-9 de la Pena, 2020, Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review, Rep Pract Oncol Radiother, 25, 637, 10.1016/j.rpor.2020.04.021 Chang, 2011, Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis, Cancer, 117, 4060, 10.1002/cncr.25997 Py, 2021, Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer, Cancer Radiother, 25, 350, 10.1016/j.canrad.2021.01.004 Yu, 2021, Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases, Cancer Res Treat Stera, 2021, Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort, Radiother Oncol, 158, 230, 10.1016/j.radonc.2021.02.036 Voglhuber, 2021, Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival, BMC Cancer, 21, 780, 10.1186/s12885-021-08488-y Lee, 2020, Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review, Radiother Oncol, 145, 63, 10.1016/j.radonc.2019.12.004 Herfarth, 2001, Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial, J Clin Oncol, 19, 164, 10.1200/JCO.2001.19.1.164 Schefter, 2005, A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases, Int J Radiat Oncol Biol Phys, 62, 1371, 10.1016/j.ijrobp.2005.01.002 McPartlin, 2017, Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases, Int J Radiat Oncol Biol Phys, 99, 388, 10.1016/j.ijrobp.2017.04.010 Mendez, 2021, The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases, Int J Radiat Oncol Biol Phys, 109, 1377, 10.1016/j.ijrobp.2020.11.045 Franzese, 2019, Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy, Radiother Oncol, 133, 220, 10.1016/j.radonc.2018.10.024 Ohri, 2021, Local Control After Stereotactic Body Radiation Therapy for Liver Tumors, Int J Radiat Oncol Biol Phys, 110, 188, 10.1016/j.ijrobp.2017.12.288 Pitroda, 2018, Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis, Nat Commun, 9, 1793, 10.1038/s41467-018-04278-6 Jethwa, 2020, Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer, Radiother Oncol, 146, 29, 10.1016/j.radonc.2020.02.008 O'Cathail, 2020, Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy, Radiother Oncol, 151, 280, 10.1016/j.radonc.2020.08.012 Jackson, 2018, Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases, Int J Radiat Oncol Biol Phys, 100, 950, 10.1016/j.ijrobp.2017.12.014